Received Aug 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | XN575 | IM / RA |
Diffuse maculopapular rash on entire body; no medical management as what not particularly bothersome to patient. Rash began 24 hours after injection and has persisted from 4-5 days following. Rash does seem to be improving.
Denies
Mild persistent asthma
none
none
None